Commit To Buy Progenics Pharmaceuticals At $7, Earn 12.9% Using Options
January 20, 2017 at 13:10 PM EST
Investors considering a purchase of Progenics Pharmaceuticals, Inc. (PGNX) shares, but tentative about paying the going market price of $8.79/share, might benefit from considering selling puts among the alternative strategies at their disposal..
